Better Understanding of Phosphoinositide 3-Kinase (PI3K) Pathways in Vasculature: Towards Precision Therapy Targeting

D Tsvetkov1, A Shymanets, Yu Huang

  • 1Charité University Medicine Berlin, Experimental and Clinical Research Center, Section Nephrology/Intensive Care, Berlin, 13125, Germany. maik.gollasch@charite.de.

Insights

Phosphoinositide 3-kinase alpha (PI3Kα) regulates arterial vasoconstriction. Inhibiting PI3Kα reduces blood vessel contraction, highlighting its cardiovascular role and potential therapeutic applications.

Area of Science:

  • Molecular Biology
  • Cardiovascular Physiology
  • Pharmacology

Background:

  • The PI3K-AKT-mTOR pathway regulates critical cellular functions like growth and metabolism.
  • PI3Kα is a key target in gene therapy for cancer due to its role in tumor progression and angiogenesis.
  • The function of PI3K isoforms in vascular tone and blood flow regulation remains largely unexplored.

Purpose of the Study:

  • To investigate the contribution of PI3K isoforms to arterial vasoconstriction.
  • To determine the specific role of PI3Kα in regulating vascular tone.

Main Methods:

  • Utilized isoform-specific PI3K inhibitors and PI3Kγ/δ deficient mice.
  • Employed wire myography to assess isometric contractions in isolated murine mesenteric arterial rings.
  • Measured phenylephrine-induced vasoconstriction responses.

Main Results:

  • Pan PI3K inhibitors (wortmannin, LY294002) significantly inhibited phenylephrine-dependent vasoconstriction.
  • PI3Kα-specific inhibitors (A66, PI-103) also reduced vasoconstriction, while PI3Kβ inhibitor (TGX 221) had no effect.
  • Arteries from PI3Kγ/δ deficient mice exhibited normal vasoconstriction, indicating these isoforms are not critical for this process.

Conclusions:

  • PI3Kα is a crucial downstream mediator in G-protein coupled receptor (GPCR) signaling, contributing to arterial vasoconstriction via α1-adrenergic receptors.
  • PI3Kα plays a significant regulatory role in the cardiovascular system.
  • These findings expand therapeutic strategies targeting PI3Kα beyond cancer, including its potential in managing tumor angiogenesis and regional blood flow.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.7K